Insigneo Advisory Services’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $590K | Buy |
1,325
+238
| +22% | +$106K | 0.05% | 299 |
|
|
2025
Q1 | $527K | Sell |
1,087
-173
| -14% | -$83.9K | 0.05% | 290 |
|
|
2024
Q4 | $507K | Sell |
1,260
-54
| -4% | -$21.7K | 0.05% | 294 |
|
|
2024
Q3 | $611K | Buy |
1,314
+65
| +5% | +$30.2K | 0.06% | 274 |
|
|
2024
Q2 | $596K | Buy |
1,249
+646
| +107% | +$308K | 0.07% | 255 |
|
|
2024
Q1 | $252K | Buy |
603
+63
| +12% | +$26.3K | 0.03% | 424 |
|
|
2023
Q4 | $220K | Buy |
+540
| New | +$220K | 0.03% | 403 |
|
|
2023
Q3 | – | Sell |
-1,084
| Closed | -$381K | – | 400 |
|
|
2023
Q2 | $381K | Buy |
+1,084
| New | +$381K | 0.07% | 243 |
|